GBIO
GBIO
NASDAQ · Biotechnology

Generation Bio Co

$5.34
-0.40 (-6.97%)
As of Feb 8, 2:21 PM ET ·
Analyst Consensus
Buy
11
Analysts
Moderate
Coverage
Buy 7 64%
Hold 4 36%
Sell 0 0%
Price Target
Analyst Price Target +226.6% upside
Low Target $9.95
Average Target $17.44
High Target $18.08
Current Price $5.34
Current
$5.34
Target
$17.44
$9.95 $17.44 avg $18.08
Scenario Analysis
Bear Case
$9.95
86.3%
Low target
Base Case
$17.44
+226.6%
Avg target
Bull Case
$18.08
+238.6%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$13.64
-60.9% from high
52-Week Low
$10.02
+-46.7% from low
Target vs 52W High
$17.44
+27.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%